Candel Therapeutics progresses Phase 3 trial for treatment in high-risk localized prostate cancer

712 views

Proactive Investors

10 months ago

Candel Therapeutics progresses Phase 3 trial for treatment in high-risk localized prostate cancer

Candel Therapeutics progresses Phase 3 trial for treatment in high-risk localized prostate cancer